as on January 1, 2026 at 4:01 pm IST
Day's Low
Day's High
0.93%
Downside
0.70%
Upside
52 Week's Low
52 Week's High
48.37%
Downside
9.19%
Upside
as on January 1, 2026 at 4:01 pm IST
Market Cap
₹910.47 Cr
Return on Equity (ROE)
6.39
PE Ratio (TTM)
46.08
Return on capital employed (ROCE)
8.37
Industry PE ratio
41.53
Beta (LTM)
0.67
P/B Ratio
1.64
Dividend Yield
0PEG Ratio
14.54
Quarterly Earnings Growth YOY
-5.42
EPS (TTM)
7.97
Sector
Pharmaceuticals
Book Value
128.75
Technical Analysis
Bullish
View Technical Analysis
as on January 1, 2026 at 4:01 pm IST
Sakar Healthcare in the last 5 years
Lowest (13.06x)
May 12, 2022
Industry (41.53x)
December 31, 2025
Today (46.08x)
December 31, 2025
Highest (71.76x)
January 24, 2024
Today’s Price to Earnings Ratio: 46.08x
Compare market cap, revenue, PE, and other key metrics of Sakar Healthcare with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 910.47 | 63.98% | 0.62 | 17 | 177 | |
| NA | 73.98 | -5.62% | 0.00 | 4 | 61 | |
| NA | 726.36 | 1.67% | 0.62 | 38 | 629 | |
| NA | 12.95 | -7.88% | 0.00 | NA | 51 | |
| BUY | 8,298.77 | 0.43% | 0.72 | 3,597 | 4,565 |
Get share price movements and forecasts by analysts on Sakar Healthcare.
Source: S&P Global Market Intelligence
Search interest for Sakar Healthcare Ltd Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:32% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Sakar Healthcare.
Sakar Healthcare Ltd’s net profit fell -5.42% since last year same period to ₹4.54Cr in the Q2 2025-2026. On a quarterly growth basis, Sakar Healthcare Ltd has generated -2.78% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, SAKAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Revenue Rich
![]()
Revenue is up for the last 6 quarters, 41.61 Cr → 58.78 Cr (in ₹), with an average increase of 6.6% per quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 52.86% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.6% return, outperforming this stock by 74.0%
Profit Down
![]()
Netprofit is down for the last 3 quarters, 5.76 Cr → 4.54 Cr (in ₹), with an average decrease of 10.9% per quarter
Price Dip
![]()
In the last 7 days, SAKAR stock has moved down by -3.4%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 13.41% to 13.31% in Sep 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 22.48% to 22.41% in Sep 2025 quarter
| Organisation | Sakar Healthcare Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| CEO | Sanjay S Shah. |
| E-voting on shares | Click here to vote |
Sakar Healthcare share price today stands at ₹406.9 as on at the close of the market. Sakar Healthcare share today touched a day high of ₹409.75 and a low of ₹403.1.
Sakar Healthcare touched a 52 week high of ₹444.3 and a 52 week low of ₹210.1. Sakar Healthcare share price today i.e. is closed at ₹406.9, which is -8.42% down from its 52 week high and 93.67% up from its 52 week low.
Sakar Healthcare market capitalisation is ₹910.47 Cr as on .
To buy Sakar Healthcare shares, you need to follow these steps:
Sakar Healthcare trading volume is 4,986.00 as on . This means that 4,986.00 shares of Sakar Healthcare were bought and sold on the stock market during today's trading session.